Published on 13 May 2022 on Zacks via Yahoo Finance
Medtronic plc MDT is gaining from continued recovery from pandemic-led impact. Strong growth momentum observed in international diabetes markets buoys optimism. The increasing market share gains across several businesses seem encouraging too. However, tough competition and macroeconomic woes raise apprehension.
In the past year, the Zacks Rank #3 (Hold) stock lost 18.6% compared with a 26.9% fall of the industry and a 4.6% decline of the S&P 500.
The renowned medical-device company has a market capitalization of $137.03 billion. Its earnings surpassed estimates in the trailing four quarters delivering an average surprise of 3.9%.